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Leishmaniasis is a complex disease that is caused by parasites of the Leishmania genus.
Leishmania are further classified into several complexes, each of which can engage in
distinct interactions with mammalian hosts resulting in differing disease presentations. It
is therefore not unexpected that host immune responses to Leishmania are variable. The
induction of interferon gamma (IFN-γ) and response to it in these infections has received
considerable attention. In this review, we summarize our current understanding of some
of the host responses during Leishmania infections that are regulated by IFN-γ. In addition,
studies that explore the nature of parasite-derived molecular mediators that might affect
the host response to IFN-γ are also discussed.
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INTRODUCTION
Seminal studies on experimental infections of Leishmania major
in C57BL/6 and BALB/c inbred mouse strains correlated para-
site control with the elaboration of interferon gamma (IFN-γ) by
CD4+ T cells and uncontrolled infections with the absence of IFN-
γ in the C57BL/6 and BALB/c mice, respectively (Scott et al., 1989;
Reiner and Locksley, 1995). Those historic studies of the immune
response to Leishmania defined a disease model that supported the
in vitro observations of Mosmann et al. (1986) that T cell responses
can be subdivided on the basis of their cytokine production pro-
file after re-stimulation. Attempts to explain the molecular basis
of cytokine responses in Leishmania infections, their universal-
ity and the importance and potential for exploitation in efforts
to control Leishmania infections has fueled numerous studies by
immunologist; from an academic viewpoint, it has been that gift
that has kept on giving. Outstanding questions that continue to
be addressed are: (1) What factors limit the function of IFN-γ in
the course of an infection? (2) When and how and does IFN-γ
contribute to parasite control? (3) What mechanisms do parasites
deploy to modulate either the environment in which IFN-γ has
to function or modulate specific actions of IFN-γ? In this review,
we summarize recent studies that have considered some of these
questions. For a more complete assessment of the role of IFN-γ
in leishmaniasis, other recent reviews on the immune response in
Leishmania infections should be considered as well. Details on the
biology of IFN-γ are presented in other contributions in this issue.
INFECTIONS WITH LEISHMANIA SPECIES ARE
DIFFERENTIALLY RESPONSIVE TO IFN-γ
There is ample evidence that IFN-γ and other cytokines that
are secreted in the course of an infection have counter regula-
tory effects on the production and functions of each other. These
counter-regulation mechanisms are in action at both the tran-
scriptional and translational levels during T cell priming and
differentiation stages for mouse and human CD4+ T helper (Th)
subsets (Kaiko et al., 2008; Rautajoki et al., 2008). It is known that
IFN-γ−/− or IFN-γR−/− C57BL/6 mice become highly susceptible
to L. major infection, accompanied by an expansion of Th2-type
responses (Swihart et al., 1995; Pinheiro and Rossi-Bergmann,
2007). However, IFN-γ−/− C57BL/6 mice are as susceptible to
L. amazonensis infection as the wild-type mice, at least for the
first 2 months of infection, but they have more severe disease
afterward (in the absence of an IL-4 dominance) (Pinheiro and
Rossi-Bergmann, 2007). These observations indicate that IFN-γ
is required for the control of L. major infection and can restrain
pathogenic Th2 cell expansion, while IFN-γ is not essential for the
control of L. amazonensis at the first few weeks of infection (Pin-
heiro and Rossi-Bergmann, 2007). These studies of L. major and L.
amazonensis with side-by-side immunological studies in primary
(Ji et al., 2003) and secondary infections (González-Lombana et al.,
2008), suggest distinct mechanisms underlying host susceptibility
to New World and Old World cutaneous leishmaniasis.
REGULATORY ROLE OF IFN-γ IN LEISHMANIA INFECTIONS
Interferon gamma is not secreted in a vacuum; IL-10 and other
Th2 cytokines exert critical effects on IFN-γ both at the level
of induction and at the level of effector function, which then
determine the course of infections. The reader is directed to
recent reviews that have considered these interactions (Nylén and
Sacks, 2007; Alexander and Brombacher, 2012). In this review,
we will highlight recent findings regarding the cross-talk between
IFN-γ and CXCR3-cognate chemokines and its impact on Leish-
mania infection. At present, much less information is known
as to how IFN-γ regulates other pro-inflammatory chemokines
in parasitic diseases. CXCR3 is a common primary receptor
for three chemokines: CXCL9/Mig (also known as monokine
induced by interferon gamma), CXCL10/IP-10 (also known
as interferon-inducible protein-10), and CXCL11/I-TAC (also
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known as interferon-inducible T cell alpha-chemoattractant),
which are structurally and functionally related molecules within
the non-ELR CXC chemokine subgroup (Müller et al., 2010; Liu
et al., 2011a,b). These chemokines are not constitutively expressed,
but are up-regulated in a pro-inflammatory cytokine milieu, with
a major function of selectively recruiting immune cells to inflam-
mation sites. In the context of Leishmania infection, we and others
have provided several lines of evidence that reveals a beneficial role
of these CXC chemokines in parasite control.
The first line of evidence for a protective role of CXCL
chemokines comes from L. donovani infection in mice. Earlier
studies with IFN-γ−/− mice and B6.Jalpha281−/− mice (lacking
NKT cells) have confirmed an absolute requirement for IFN-γ
for sustained (24 h) expression of CXCL10 mRNA in L. donovani
infection; an indispensable role for invariant NKT cells for the
regulation of hepatic CXCL10 gene expression during the infec-
tion, because both CD3−NK1.1+ NK cells and CD3intNK1.1+
NKT cells are the early sources of IFN-γ production (Svensson
et al., 2005). Recently, Gupta et al. (2011) have observed that
CXCL10-treated, L. donovani-infected BALB/c mice displayed a
strong host-protective Th1 response, accompanied by a marked
decrease in immunosuppressive Treg cells and TGF-β- and IL-10-
secreting CD4+ T cells. Using a different approach, Majumder
et al. (2012) have documented that CXCL10 is critical for the
generation of protective CD8+ T cell responses induced by leish-
manial antigen-pulsed, CpG-activated DC, because depletion of
CXCL10 hampered CD8+ T cell activation and the generation of
perforin and granzyme B. These studies suggest a role of CXCL
chemokines on the regulatory functions of T cells and DC, which
might be helpful in combating Leishmania-induced pathogenesis
and boosting protective immunity. In contrast, it has been found
that CXCR3−/−mice can mount an efficient Th1 response, recruit
T cells to the liver, and control L. donovani growth, even though
they have a delayed onset of hepatic inflammation and granuloma
formation (Barbi et al., 2007). The self-limiting nature of L. dono-
vani infection in inbred strains of mice may partially account for
the trivial protective effects in these knockout mice.
The second line of evidence for a protective role of CXCL10
comes from a murine model of L. amazonensis infection, for
which nearly all inbred strains of mice are genetically suscep-
tible to. We have revealed that pre-treatment with recombinant
CXCL10 (100 ng/ml) significantly reduces L. amazonensis infec-
tion in bone marrow macrophages derived from BALB/c, C57BL/6,
and C3H/HeJ mice, partially via a NO-mediated mechanism
(Vasquez and Soong, 2006). Also, treatment with CXCL10 pref-
erentially stimulates IL-12 production over IL-10 production in
naïve and L. amazonensis-infected CD11c+CD45RB− DC, and
promotes IFN-γ production and IL-12Rβ2 chain expression by
CD4+ T cells isolated from naïve or infected mice (Vasquez
et al., 2008). The in vitro observations indicate positive feed-backs
between IFN-γ and CXCL10 production for better control of the
infection. Indeed, we have found that mice receiving subcutaneous
injections of CXCL10 (100 ng) at days 1, 3, and 7 of infection
with L. amazonensis have attenuated cutaneous lesions, as well
as a 7- and 3.5-fold increase in IFN-γ and IL-12 production in
re-stimulated lymph node cells (Vasquez and Soong, 2006). How-
ever, the major cellular sources of CXCL10 production during
Leishmania infection in vivo have not yet been evaluated, although
the top candidates may include CD4+ Th1 cells, CD8+ T cells, NK
cells (Müller et al., 2010), NK T cells (Svensson et al., 2005; Beattie
et al., 2010), as well as macrophages exposed to long-term culture
(less-virulent) Leishmania (de Souza et al., 2010).
In agreement with the findings from murine infection models,
clinical studies from healthy volunteers and leishmaniasis patients
also suggest an involvement of CXCR3 chemokines in protec-
tion and disease pathogenesis. Several comparative studies have
been conducted with L. braziliensis (the etiologic agent for cuta-
neous leishmaniasis and hyper-reactive mucosal leishmaniasis in
South America), as well as L. amazonensis (the etiologic agent
for cutaneous leishmaniasis and hypo-reactive disuse cutaneous
leishmaniasis in South America). It has been reported that the
crude antigen extracts of L. braziliensis (LbAg) are more potent
than antigens of L. amazonensis (LaAg) in stimulating IFN-γ-
producing cells and multi-functional CD4+ T cells of American
cutaneous leishmaniasis patients (Macedo et al., 2012), and that
LbAg also stimulate CXCL10 production in human PMBC, in
a manner that correlates to the IFN-γ-positivity but not DTH-
positivity (Schnorr et al., 2012). Using healthy donor PBMCs in
parasite infection, we detected an enhanced expression of CXCL10
and other CC chemokines (CCL2-4) in responses to promastigote
forms of L. braziliensis but not those of L. amazonensis (Vargas-
Inchaustegui et al., 2010). Of note, CD14+ monocytes, but not
CD3+ T cells or CD3−CD56+ NK cells, were the dominant cells
that expressed CXCR3 on their cell surface and produced CXCL10
and IFN-γ in response to L. braziliensis infection in vitro. Given
that serum samples from American tegumentary leishmaniasis
(ATL) patients, especially in those of the mucosal leishmaniasis
cases, have elevated levels of CXCL10, CCL4, and soluble tumor
necrosis factor (TNF) receptor II (sTNFRII) (Vargas-Inchaustegui
et al., 2010), and that the levels of CXCL9 were elevated in sera
from L. braziliensis-infected, disseminated leishmaniasis patients,
the biological functions of different CXCR3 chemokines during
Leishmania infection in humans need to be carefully evaluated.
UNRESPONSIVENESS OF INFECTED CELLS TO IFN-γ
Cells infected with either the promastigote or amastigote forms
of the parasite are less responsive to stimuli such as LPS that
elicits IFN-γ production or IFN-γ itself that activates the anti-
parasitic effector response of macrophages (Abu-Dayyeh et al.,
2010; Matte and Descoteaux, 2010). Studies with mice that have
a selective impairment of IFN-γ signaling in macrophage lineage
cells have clearly demonstrated the critical role of IFN-γ-activated
macrophages for the control of protozoan parasitic infections
in vivo (Lykens et al., 2010). Studies assessing these responses have
employed varying readouts to assess cell activation. These readouts
have included evidence of transcription of expected genes, produc-
tion of iNOS, evidence of translocation of signaling intermediates
into the nucleus and phosphorylation of signaling intermediates
in the cytosol. Each of these readouts has confirmed that Leishma-
nia infection has a suppressive effect on responsiveness to IFN-γ.
How and whether this reduced responsive of infected cells affects
the course of infection is considered later. It is of interest that
infections with amastigote and promastigote forms engage differ-
ent mechanisms to accomplish the effect on the host cell. A study
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by Abu-Dayyeh et al., 2010 compared the effect of promastigotes or
amastigotes on the activation of host protein tyrosine phosphatase
(PTP), activation of the transcription factors: signal transducers
and activator of transcription (STAT); AP-1 and NF-κB, which are
signaling intermediates that have been shown to mediate the effects
of LPS and IFN-γ (Zhang and Ghosh, 2000; Johnson et al., 2012).
In agreement with previous studies, they observed that both para-
site forms inhibit the activation of STAT1 and AP-1. Furthermore,
infection with both parasite forms blocked NF-κB translocation
into the nucleus by degradation of the p65 subunit; interestingly,
in light of the fact that the products of p65 degradation was dif-
ferent depending the infecting parasite form, it was proposed that
distinct parasite molecules might be responsible for targeting NF-
κB activation. Our knowledge of the identity of such molecules is
still limited. The only molecule that has been characterized with
this effector function is the cysteine proteinase (LmCPb). Abu-
Dayyeh et al., showed that this molecule not only targets NF-κB
but it also targets PTP-1b. How LmCPb recognizes these targets is
presently not known. Moreover, the mechanism by which this and
other parasite-derived molecules that are expressed within the par-
asitophorous vacuole access targets in the cytosol has thus far been
a matter of speculation (Mottram et al., 2004). In a different study
that evaluated the mechanism by which amastigote forms limit the
responsiveness of infected cells, the function of importin-α5 that
mediates the translocation of STAT1 among other transcription
factors from the cytosol to the nucleus was shown to be inhibited,
which prevented the activation of Interferon regulatory factor 1
(IRF-1) (Matte and Descoteaux, 2010). The authors speculated
on the likely existence of parasite-derived molecules that target
importin-α5 function.
In light of the evidence that Leishmania infection reduces
responsiveness of infected cells to IFN-γ, it is not known what
role the remnant muted response plays in the development of a
Leishmania lesion. Since responses to cytokines are dependent on
the concentration of the cytokine, the local concentration of IFN-
γ might determine in large part what will be the cellular responses
there. Obtaining a greater understanding of the microanatomy of
IFN-γ and other CD4+ T cell effector activity at the site of a lesion
is therefore of great interest. Delivery of cytokines such as IFN-γ is
known to be strictly limited to the immunological synapse in vitro
(Huse et al., 2006). By using static imaging of effector CD4+ T
cells in bacille calmette–Guérin (BC2013G)-induced granulomas,
Egen et al. (2011) have shown that IFN-γ is localized at the T
cell-antigen-presenting cell (APC) interface in vivo, suggesting a
strictly localized effector activity at the site of infection. However,
this view of “high local specificity for delivered cytokines” is chal-
lenged and greatly expanded by a recent study of Müller et al.,
that involves a self-healing mouse model of cutaneous L. major
infection. In this study, the authors asked whether CD4+ T cells
have to engage each L. major-infected cell individually in order
for efficient parasite clearance (Müller et al., 2012). They found
that although CD4+ T cells formed stable contacts with a limited
number (10%) of infected cells, such contacts efficiently activated
intracellular defense mechanisms in infected cells by producing
a gradient of effector signals (including IFN-γ and iNOS expres-
sion), which would extend more than 80µm beyond the site of
T cell-APC interactions. This implied that infected cells within
that range can respond to those IFN-γ levels to elaborate anti-
Leishmania mechanisms. These findings are exciting as they help
us understand some issues that were raised by previous observa-
tions. Specifically, several reports had shown that infected cells
harboring live parasites are poor antigen presenters of endoge-
nously synthesized parasite antigens to CD4+ T cells (Kima et al.,
1996; Prina et al., 1996), which implied that cytokine production
within the lesion would be limited. With the results of Müller
et al., it is possible to envision a scenario in which APCs that
acquire antigens from dead parasites can activate CD4+ T cells to
unleash cytokines that limit the development of the lesion. The
studies of Müller et al., also shed new light on immune-mediated
parasite control in self-healing cutaneous leishmaniasis that are
known to trigger strong and sustained IFN-γ production for effi-
cient control of L. major and L. braziliensis infection in genetically
resistant mouse strains (Pagan et al., 2013). In these self-healing
mouse models, and possibly subclinical human infections, CD4+
T cells can extend their effector functions beyond the immuno-
logical synapse and activate bystander effector activities, including
CXCL10and iNOS, to control intracellular pathogens.
This view of cytokine gradient-based parasite control also helps
understand chronic and non-healing leishmaniasis associated with
L. donovani, L. amazonensis, and L. mexicana infections in mouse
and humans. Since these parasite species can persist for months or
years and replicate in target cells in the face of appreciable levels of
IFN-γ, we envision several possible mechanisms for non-healing
infections. Firstly, the concentration of IFN-γ may not be suf-
ficiently high, or the duration of IFN-γ production may not be
sustained long enough, to reach other infected or bystander cells
in distance. This possibility is supported by many in vitro stud-
ies at the single-cell level (Vargas-Inchaustegui et al., 2008, 2009;
Pereira et al., 2009; Xin et al., 2011; Macedo et al., 2012). Secondly,
the expression of IFN-γ receptor may not be sufficiently high in
bystander cells to respond to IFN-γ. The depressed expression of
IFN-γ receptor in infected cells have been reported (Ji et al., 2003),
but evidence for IFN-γ receptor expression in bystander cells, or
for local unresponsiveness, is still missing. Further evaluation at
the tissue and molecular levels, either via immuno-histochemical
staining or in situ RT-PCR analysis, will be helpful to test this
possibility. Thirdly, IFN-γ production by itself is not sufficient to
activate the effector functions in infected or nearly bystander cells.
An increase in IFN-γ single-positive T cells by itself is not sufficient
to protect mice against primary infection, or predict vaccine-based
protection in humans and in mice (Xin et al., 2011; Macedo
et al., 2012). Efficient control of these parasite species, there-
fore, needs multiple pro-inflammatory cytokines (IFN-γ, IL-2, and
TNF-α), as well as leishmaniacidal chemokines such as CXCL10
(de Souza et al., 2010; Vargas-Inchaustegui et al., 2010). Finally,
there is increasing evidence that some parasite species/stages (such
as amastigotes of L. amazonensis) are relatively resistant to IFN-
γ- and NO/ROS-mediated killing in infected macrophages (Qi
et al., 2004; Wanasen et al., 2007), as well as in cell-free medium
(Soong et al., 2012). While much higher levels of effector mol-
ecules are required to kill parasites in the L. donovani and L.
mexicana complexes, these parasites are often highly competent
in repressing host Th1-type responses or utilizing such responses
for immunopathogenesis (Soong et al., 2012).
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CONCLUSION
Interferon gamma plays important roles in the development
and subsequent control of Leishmania infections. It and other
cytokines and chemokines exert effects on each other that
influence the course of infection. Leishmania parasites elabo-
rate factors that modulate activities induced by IFN-γ. It is
anticipated that greater insight into these interactions will be
obtained in future studies of Leishmania lesions at the cellular
level.
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